의약품 바이알 시장 : 업계 동향과 세계 예측 - 사용되는 제조 재료 유형별, 멸균 상태별, 주요 지역별

Pharmaceutical Vials Market: Industry Trends and Global Forecasts - Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies

US $ 4,799 ￦ 6,691,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,758,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,778,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,096,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

의약품 바이알 시장 : 개요

세계의 의약품 바이알 시장 규모는 올해, 110억 3,000만 달러에 달했습니다. 이 시장은 예측 기간 중 6%의 CAGR로 확대할 것으로 예측됩니다.

시장 규모 및 기회 분석은 다음과 같은 매개 변수에 따라 세분화되어 있습니다.

사용된 제조 재료 유형

• 유리
• 플라스틱

멸균 상태

• 멸균 전
• 비멸균

주요 지역

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 북아프리카
• 기타 지역

의약품 바이알 시장 : 성장과 동향

의약품 유리 바이알과 같은 1차 포장재는 포장된 치료제와 직접 접촉하므로 의약품의 안정성, 유효성, 안전성을 유지하는 데 중요한 역할을 합니다. 또한 의약품의 1차 포장재는 의약품의 무균성과 품질 유지에 도움을 주며, 의약품의 동일성과 관련된 정보 및 경우에 따라서는 투약 지침서를 제공합니다. 또한 비경구 제제에 대한 높은 수요와 백신 접종 캠페인 증가로 인해 이러한 제제를 대량으로 보관하고 전 세계에 배포하기 위한 안전하고 고품질의 의약품 바이알이 절실히 요구되고 있습니다.

가장 선호되는 포장 시스템임에도 불구하고 기존 바이알은 열악한 조건에서 파손 가능성, 포장에 관련 정보(일련번호 및 배치 번호)의 부재, 박리 가능성 등 특정 문제를 안고 있는 경우가 많습니다. 따라서 일부 제약 바이알 제조업체는 더 나은 포장 솔루션을 만들기 위해 기존 제약 바이알과 관련된 앞서 언급 한 문제를 극복하기 위해 새로운 기술을 모색하고 있습니다. 실제로 제약 바이알 제조업체는 차세대 의약품의 변화하는 수요에 대응하기 위해 끊임없이 혁신하고 더 새롭고 더 나은 포장 솔루션을 만들고 있습니다. 멸균 바이알의 사용, 다양한 코팅 재료의 개발, 스마트 약물전달 기술의 채택 등이 이 분야의 발전의 예입니다.

의약품 바이알 시장 : 주요 인사이트

이 보고서는 세계 제약 바이알 시장의 현황을 조사하고 업계의 잠재적인 성장 기회를 파악합니다. 이 보고서의 주요 조사 결과는 다음과 같습니다.

• 현재, 약 95개 업체에서 240개 이상의 의약품 바이알을 판매/개발하고 있으며, 이들 업체는 대부분 북미, 유럽 등 선진국에 기반을 두고 있습니다.
• 의약품 바이알의 대부분은 유리로 만들어졌으며, 다양한 용량이 있습니다.

• 다양한 장점으로 인해 유리는 의약품 바이알에 사용되는 가장 선호되는 제조 재료로 부상했습니다. 일반적으로 사용되는 유리의 유형에는 유형 I 붕규산 유리(65%) 및 유형 III 소다 석회 유리(16%)가 포함됩니다.
• 의약품 바이알의 대부분(60%)은 50ml 미만의 의약품을 담을 수 있는 용량이지만, 100ml 이상의 치료제를 담을 수 있는 바이알은 극히 일부(8%)에 불과합니다.
• 의약품 바이알의 60% 이상이 스크류 캡으로 사용하도록 설계되었으며, 1-Clic(R) Vial System, CryoClear(TM) 바이알, NextGen(TM) V-Vial(R), Pyrofree(R) 바이알, Sterile CryoSure(R) 바이알, Sterile CryoSure(R) 바이알, 등이 있습니다. Sterile CryoSure(R) 바이알 등이 있습니다.
• 경쟁 우위를 구축하기 위해 업계 관계자들은 각자의 제품 포트폴리오를 강화하기 위해 기존 역량을 적극적으로 업그레이드하고 새로운 역량을 추가하고 있습니다.
• 수년 동안 업계 기업은 자체 의약품 바이알을 더욱 발전시키고 개선하기 위해 몇 가지 거래를 성사시켜왔습니다.
• 이 분야의 제휴 활동은 지난 수년간 CAGR 30% 이상으로 증가했습니다.
• 기존 기업도 신규 진출기업도 과거에는 전략적 파트너십을 맺은 바 있습니다.
• 현재 업계 동향은 점점 더 복잡해지는 의약품의 대규모 및 특수한 생산 및 포장 요구 사항을 충족시키기 위해 혁신적인 포장 솔루션에 대한 요구가 증가하고 있음을 입증합니다.
• 약 40개 기업이 다양한 자유도를 가진 다양한 로봇 기계를 제공하고 있으며, 생산성과 비용 최적화를 위한 놀라운 기회를 제공한다고 주장하고 있습니다.
• 의약품 바이알은 COVID-19 팬데믹 기간 중 새로운 백신과 실험용 치료제를 대량으로 보관하고 포장하기 위해 높은 수요를 보이고 있습니다.

• 제약 바이알의 추정 시장 기회는 다양한 유형의 제조 재료, 멸균 상태 및 지역적 지역에 걸쳐 잘 분포되어 있을 것으로 예측됩니다.

의약품 바이알 시장의 참여 기업 예

• Chongqing Zhengchuan Pharmaceutical Packaging
• Corning
• DANYANG XIANGHE PHARMACEUTICAL PACKAGING
• DWK Life Sciences
• Gerresheimer
• Ningbo Zhengli Pharmaceutical Packaging
• Nipro
• Origin Pharma Packaging
• Pacific Vial Manufacturing
• SCHOTT
• SGD Pharma
• Shandong Pharmaceutical Glass
• Stevanato Group
• Thermo Fisher Scientific
• Worldwide Glass Resources

목차

제1장 서문

제2장 개요

제3장 서론

• 챕터 개요
• 의약품 포장
• 의약품 바이알
• 의약품 바이알에서의 혁신

제4장 시장 구도

• 챕터 개요
• 의약품 바이알 : 시장 구도
• 의약품 바이알 : 제조업체 리스트

제5장 기업 경쟁력 분석

• 챕터 개요
• 전제와 주요 파라미터
• 조사 방법
• 의약품 바이알 : 기업 경쟁력 분석

제6장 기업 개요 : 북미의 의약품 바이알 제조업체

• 챕터 개요
• Corning
• DWK Life Sciences
• Pacific Vial Manufacturing
• Thermo Fischer Scientific
• Worldwide Glass Resources

제7장 기업 개요 : 유럽의 의약품 바이알 제조업체

• 챕터 개요
• Gerresheimer
• Origin Pharma Packaging
• SCHOTT
• SGD Pharma
• Stevanato Group

제8장 기업 개요 : 아시아태평양의 의약품 바이알 제조업체

• Chongqing Zhengchuan Pharmaceutical Packaging
• Danyang Xianghe Pharmaceutical Packaging
• Ningbo Zhengli Pharmaceutical Packaging
• Nipro
• Shandong Pharmaceutical Glass

제9장 파트너십과 협업

• 챕터 개요
• 파트너십 모델
• 의약품 바이알 : 파트너십과 협업 리스트

제10장 의약품 포장의 향후 동향

• 챕터 개요
• 현대 약물전달 디바이스의 사용을 통한 약물 자기 치료의 선호도
• 개량된 포장 부품의 개발과 제조 비용의 최적화 노력
• 모듈러 시설의 이용 가능성
• 맞춤형 치료에 대한 수요와 선호도의 증가
• Fill/Finish 공정의 자동화에 관한 규정의 증가
• 파트너십 활동의 급증
• 개발도상 지역에서 업계 이해관계자에 의한 구상의 증가
• 결론

제11장 수요 분석

• 챕터 개요
• 범위와 조사 방법
• 2035년까지 의약품 바이알의 세계 수요
• 결론

제12장 시장 예측과 기회 분석

• 챕터 개요
• 예측 조사 방법과 주요 전제조건
• 세계의 의약품 바이알 시장(-2035년)

제13장 사례 연구 : 의약품 포장용 로봇

• 챕터 개요
• 제약 업계에서 로봇의 역할
  • 로봇 시스템 선택시 주요 고려사항
  • 로봇 시스템의 이점
  • 로봇 시스템의 결점
• 제약 업계용 로봇을 제공하는 기업
• 의약품 포장용 로봇 시스템을 통합한 장비를 제공하는 기업
  • Aseptic Technologies
  • AST
  • Bosch Packaging Technology
  • Dara Pharmaceutical Packaging
  • Fedegari Group
  • IMA
  • Steriline
  • Vanrx Pharmasystems

제14장 사례 연구 : 사전 멸균/RTU(READY-TO-USE) 의약품 바이알

• 챕터 개요
• 의약품 포장과 충전
• 기존 일차 포장의 한계
• RTU(READY-TO-USE) 일차 포장
• 결론

제15장 결론

제16장 이그제큐티브 인사이트

제17장 부록 1 : 표형식 데이터

제18장 부록 2 : 기업·단체 리스트

KSA

영문 목차

영문목차

PHARMACEUTICAL VIALS MARKET: OVERVIEW

As per Roots Analysis, the global pharmaceutical vials market valued at USD 11.03 billion in the current year is anticipated to grow at a CAGR of 6% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Fabrication Material Used

• Glass
• Plastic

Sterilization Status

• Pre-sterilized
• Unsterilized

Key Geographies

• North America
• Europe
• Asia- Pacific
• Latin America
• Middle East and North Africa
• Rest of the World

PHARMACEUTICAL VIALS MARKET: GROWTH AND TRENDS

Primary packaging material such as pharmaceutical glass vials play a crucial role in preserving the stability, efficacy and safety of the drug as it is in direct contact with the packaged therapeutic. Additionally, pharmaceutical primary packaging material assists in maintaining the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Moreover, given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials, for storing and distributing such formulations in large quantities, across the world.

Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vials manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. In fact, pharmaceutical vial manufacturers are constantly innovating and creating newer and better packaging solutions in order to meet the changing demands of next generation drug products. Examples of some advancements in this domain include the use of pre-sterilized vials, development of numerous coating materials and adoption of smart drug delivery technologies.

PHARMACEUTICAL VIALS MARKET: KEY INSIGHTS

The report delves into the current state of the global pharmaceutical vials market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, more than 240 pharmaceutical vials are available / being developed by close to 95 manufacturers; most of these players are based in the developed such as North America and Europe.
• Majority of the pharmaceutical vials are fabricated using glass and are available in a variety of volumes; screw caps are amongst the preferred type of vial caps used for such containers.

• Owing to the various benefits, glass emerged as the most preferred fabrication material used for pharmaceutical vials; common types of glass used include type I borosilicate glass (65%) and type III soda-lime glass (16%).
• Majority (60%) of the pharmaceutical vials have a capacity to hold less than 50 ml of drug product; however, very few (8%) vials are capable of storing more than 100 ml of therapeutic products.
• More than 60% of the pharmaceutical vials are designed to be used with screw caps; examples of such vials include 1-Clic(R) Vial System, CryoClear(TM) vials, NextGen(TM) V-Vial(R), Pyrofree vials and Sterile CryoSure(R) Vial.
• In pursuit of building a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective product portfolios.
• Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary pharmaceutical vials.
• The partnership activity in this domain has increased at a CAGR of over 30% in the past few years.
• Both established players and new entrants have forged strategic partnerships in the recent past; acquisitions emerged as the prominent type of partnership model.
• Current industry trends support the growing need for innovative packaging solutions, primarily to accommodate large scale and specialized production / packaging requirements of increasingly complex drug products.
• Close to 40 players claim to provide a wide range of robotic machinery, having different degrees of freedom, offering notable productivity and cost optimization opportunities.
• Pharmaceutical vials have been in high demand during the COVID-19 pandemic to store and package the novel vaccines and experimental therapies in large quantities.

• The estimated market opportunity for pharmaceutical vials is expected to be well distributed across different types of fabrication material, sterilization status and geographical regions.

Example Players in the Pharmaceutical Vials Market

• Chongqing Zhengchuan Pharmaceutical Packaging
• Corning
• DANYANG XIANGHE PHARMACEUTICAL PACKAGING
• DWK Life Sciences
• Gerresheimer
• Ningbo Zhengli Pharmaceutical Packaging
• Nipro
• Origin Pharma Packaging
• Pacific Vial Manufacturing
• SCHOTT
• SGD Pharma
• Shandong Pharmaceutical Glass
• Stevanato Group
• Thermo Fisher Scientific
• Worldwide Glass Resources

PHARMACEUTICAL VIALS MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the pharmaceutical vials market, focusing on key market segments, including [A] type of fabrication material used, [B] sterilization status and [C] key geographies.
• Market Landscape: A comprehensive evaluation of pharmaceutical vials, based on several relevant parameters, such as [A] type of fabrication material used for container, [B] type of fabrication material used for closure, [C] volume of vial, [D] type of vial cap, [D] sterilization status, [E] type of product, [F] compatible drug class and [G] type of formulation stored. Additionally, a comprehensive evaluation of pharmaceutical vial manufacturers based on several relevant parameters, including [A] year of establishment, [B] company size, [C] location of headquarters and [D] key players (in terms of number of products).
• Company Competitiveness Analysis: A comprehensive competitive analysis of pharmaceutical vial manufacturers, examining factors, such as [A] supplier power and [B] key product specifications.
• Company Profiles: In-depth profiles of the players engaged in the development of pharmaceutical vials, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the pharmaceutical vial domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of fabrication material involved, [D] sterilization status, [E] type of partners and [F] regional distribution of the partnerships.
• Upcoming Trends in Pharmaceutical Packaging: An in-depth analysis of key trends that are likely to impact the future adoption of novel primary packaging systems. Further, a Harvey ball analysis, focusing on the relative effect of each trend on the overall pharmaceutical packaging industry.
• Demand Analysis: A detailed analysis of the current and future demand for pharmaceutical vials, based on various parameters, such as [A] type of fabrication material used, [B] sterilization status and [C] regions.
• Case Study: A detailed discussion on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, describing the advantages of using automation / automated technologies in such processes.
• Case Study: A detailed discussion on pre-sterilized / RTU pharmaceutical vials that are currently available. Additionally, the section discusses various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Pharmaceutical Packaging
  • 3.2.1. Need for Pharmaceutical Packaging
  • 3.2.2. Types of Pharmaceutical Packaging
• 3.3. Pharmaceutical Vials
  • 3.3.1. Types of Fabrication Materials Used for Vials
    • 3.3.1.1. Glass Vials
    • 3.3.1.2. Plastic Vials
  • 3.3.2. Vial Caps
• 3.4. Innovation in Pharmaceutical Vials

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Pharmaceutical Vials: Overall Market Landscape
  • 4.2.1. Analysis by Type of Fabrication Material Used (Container)
  • 4.2.2. Analysis by Type of Fabrication Material Used (Closure)
  • 4.2.3. Analysis by Volume of Vial
  • 4.2.4. Analysis by Type of Vial Cap
  • 4.2.5. Analysis by Sterilization Status
  • 4.2.6. Analysis by Type of Product
  • 4.2.7. Analysis by Compatible Drug Class
  • 4.2.8. Analysis by Type of Formulation Stored
• 4.3. Pharmaceutical Vials: List of Manufacturers
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Location of Headquarters
  • 4.3.4. Leading Manufacturers: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions and Key Parameters
• 5.3. Methodology
• 5.4. Pharmaceutical Vials: Company Competitiveness Analysis
  • 5.4.1. Company Competitiveness: Small Manufacturers
  • 5.4.2. Company Competitiveness: Mid-sized Manufacturers
  • 5.4.3. Company Competitiveness: Large Manufacturers
  • 5.4.4. Company Competitiveness: Very Large Manufacturers

6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA

• 6.1. Chapter Overview
• 6.2. Corning
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Pharmaceutical Vials Portfolio
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. DWK Life Sciences
  • 6.3.1. Company Overview
  • 6.3.2. Pharmaceutical Vials Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. Pacific Vial Manufacturing
  • 6.4.1. Company Overview
  • 6.4.2. Pharmaceutical Vials Portfolio
  • 6.4.3. Recent Developments and Future Outlook
• 6.5. Thermo Fischer Scientific
  • 6.5.1. Company Overview
  • 6.5.2. Financial Information
  • 6.5.3. Pharmaceutical Vials Portfolio
  • 6.5.4. Recent Developments and Future Outlook
• 6.6. Worldwide Glass Resources
  • 6.6.1. Company Overview
  • 6.6.2. Pharmaceutical Vials Portfolio
  • 6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE

• 7.1. Chapter Overview
• 7.2. Gerresheimer
  • 7.2.1. Company Overview
  • 7.2.2. Financial Information
  • 7.2.3. Pharmaceutical Vials Portfolio
  • 7.2.4. Recent Developments and Future Outlook
• 7.3. Origin Pharma Packaging
  • 7.3.1. Company Overview
  • 7.3.2. Pharmaceutical Vials Portfolio
  • 7.3.3. Recent Developments and Future Outlook
• 7.4. SCHOTT
  • 7.4.1. Company Overview
  • 7.4.2. Financial Information
  • 7.4.3. Pharmaceutical Vials Portfolio
  • 7.4.4. Recent Developments and Future Outlook
• 7.5. SGD Pharma
  • 7.5.1. Company Overview
  • 7.5.2. Financial Information
  • 7.5.3. Pharmaceutical Vials Portfolio
  • 7.5.4. Recent Developments and Future Outlook
• 7.6. Stevanato Group
  • 7.6.1. Company Overview
  • 7.6.2. Pharmaceutical Vials Portfolio
  • 7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC

• 8.1. Chongqing Zhengchuan Pharmaceutical Packaging
  • 8.1.1. Company Overview
  • 8.1.2. Pharmaceutical Vials Portfolio
  • 8.1.3. Recent Developments and Future Outlook
• 8.2. Danyang Xianghe Pharmaceutical Packaging
  • 8.2.1. Company Overview
  • 8.2.2. Pharmaceutical Vials Portfolio
  • 8.2.3. Recent Developments and Future Outlook
• 8.3. Ningbo Zhengli Pharmaceutical Packaging
  • 8.3.1. Company Overview
  • 8.3.2. Pharmaceutical Vials Portfolio
  • 8.3.3. Recent Developments and Future Outlook
• 8.4. Nipro
  • 8.4.1. Company Overview
  • 8.4.2. Financial Information
  • 8.4.3. Pharmaceutical Vials Portfolio
  • 8.4.4. Recent Developments and Future Outlook
• 8.5. Shandong Pharmaceutical Glass
  • 8.5.1. Company Overview
  • 8.5.2. Pharmaceutical Vials Portfolio
  • 8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

• 9.1. Chapter Overview
• 9.2. Partnership Models
• 9.3. Pharmaceutical Vials: List of Partnerships and Collaborations
  • 9.3.1. Analysis by Year of Partnership
  • 9.3.2. Analysis by Type of Partnership
  • 9.3.3. Analysis by Year and Type of Partnership
  • 9.3.4. Analysis by Type of Fabrication Material Used
  • 9.3.5. Analysis by Sterilization Status
  • 9.3.6. Analysis by Type of Partner
  • 9.3.7. Most Active Players: Analysis by Number of Partnerships
  • 9.3.8. Analysis by Geography
    • 9.3.8.1. Region-wise Distribution
    • 9.3.8.2. Country-wise Distribution

10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING

• 10.1. Chapter Overview
• 10.2. Preference for Self-medication of Drugs, Through the Use of Modern Drug Delivery Devices
• 10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
• 10.4. Availability of Modular Facilities
• 10.5. Growing Demand and Preference for Personalized Therapies
• 10.6. Rise in Provisions for Automating Fill / Finish Operations
• 10.7. Surge in Partnership Activity
• 10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
• 10.9. Concluding Remarks

11. DEMAND ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Global Demand for Pharmaceutical Vials, Till 2035
  • 11.3.1. Analysis by Type of Fabrication Material Used
    • 11.3.1.1. Global Demand for Pharmaceutical Glass Vials, Till 2035
    • 11.3.1.2. Global Demand for Pharmaceutical Plastic Vials, Till 2035
  • 11.3.2. Analysis by Sterilization Status
    • 11.3.2.1. Global Demand for Unsterilized Pharmaceutical Vials, Till 2035
    • 11.3.2.2. Global Demand for Pre-sterilized Pharmaceutical Vials, Till 2035
  • 11.3.3. Analysis by Geography
    • 11.3.3.1. Demand for Pharmaceutical Vials in North America, Till 2035
    • 11.3.3.2. Demand for Pharmaceutical Vials in Europe, Till 2035
    • 11.3.3.3. Demand for Pharmaceutical Vials in Asia Pacific, Till 2035
    • 11.3.3.4. Demand for Pharmaceutical Vials in Middle East and North Africa, Till 2035
    • 11.3.3.5. Demand for Pharmaceutical Vials in Latin America, Till 2035
    • 11.3.3.6. Demand for Pharmaceutical Vials in Rest of the World, Till 2035
• 11.4. Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 12.1. Chapter Overview
• 12.2. Forecast Methodology and Key Assumptions
• 12.3. Global Pharmaceutical Vials Market, Till 2035
  • 12.3.1. Pharmaceutical Vials Market : Distribution by Type of Fabrication Material Used
    • 12.3.1.1. Pharmaceutical Glass Vials Market, Till 2035
    • 12.3.1.2. Pharmaceutical Plastic Vials Market, Till 2035
  • 12.3.2. Pharmaceutical Vials Market : Distribution by Sterilization Status
    • 12.3.2.1. Unsterilized Pharmaceutical Vials Market, Till 2035
    • 12.3.2.2. Pre-sterilized Pharmaceutical Vials Market, Till 2035
  • 12.3.3. Pharmaceutical Vials Market : Distribution by Geography
    • 12.3.3.1. Pharmaceutical Vials Market in North America, Till 2035
    • 12.3.3.2. Pharmaceutical Vials Market in Europe, Till 2035
    • 12.3.3.3. Pharmaceutical Vials Market in Asia Pacific, Till 2035
    • 12.3.3.4. Pharmaceutical Vials Market in Middle East and North Africa, Till 2035
    • 12.3.3.5. Pharmaceutical Vials Market in Latin America, Till 2035
    • 12.3.3.6. Pharmaceutical Vials Market in Rest of the World, Till 2035

13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING

• 13.1. Chapter Overview
• 13.2. Role of Robots in the Pharmaceutical Industry
  • 13.2.1. Key Considerations for Selecting a Robotic System
  • 13.2.2. Advantages of Robotic Systems
  • 13.2.3. Disadvantages of Robotic Systems
• 13.3. Companies Providing Robots for Use in the Pharmaceutical Industry
• 13.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
  • 13.4.1. Aseptic Technologies
  • 13.4.2. AST
  • 13.4.3. Bosch Packaging Technology
  • 13.4.4. Dara Pharmaceutical Packaging
  • 13.4.5. Fedegari Group
  • 13.4.6. IMA
  • 13.4.7. Steriline
  • 13.4.8. Vanrx Pharmasystems

14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS

• 14.1. Chapter Overview
• 14.2. Pharmaceutical Packaging and Filling
• 14.3. Limitations of Traditional Primary Packaging
• 14.4. Ready-to-Use Primary Packaging
  • 14.4.1. Sterilization of Primary Packaging Material
    • 14.4.1.1. Sterilization Techniques
  • 14.4.2. Advantages of Ready-to-Use Primary Packaging
  • 14.4.3. Cost Saving Opportunities associated with Ready-To-Use Primary Packaging
  • 14.4.4. Current Demand for Ready-To-Use Primary Packaging and Key Enablers
  • 14.4.5. List of Pre-Sterilized / Ready-to-Use Pharmaceutical Vials
• 14.5. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

• 16.1. Chapter Overview
• 16.2. Company A
  • 16.2.1. Company Snapshot
  • 16.2.2. Interview Transcript: Business Development and Technology Director
• 16.3. Company B
  • 16.3.1. Company Snapshot
  • 16.3.2. Interview Transcript: Former Project Manager of Business Development
• 16.4. Company C
  • 16.4.1. Company Snapshot
  • 16.4.2. Interview Transcript: SiO2 Materials Science

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료